EverPoint Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	$2.71M	Buy	+70,000	New	+$2.71M	0.05%	268
2015 Q3	–	Sell	-150,000	Closed	-$7.16M	–	454
2015 Q2	$7.16M	Sell	150,000 -15,000	-9%	-$716K	0.13%	198
2015 Q1	$6.55M	Buy	+165,000	New	+$6.55M	0.12%	206